Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi Past Earnings Performance
Past criteria checks 2/6
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi has been growing earnings at an average annual rate of 15.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 49.9% per year. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi's return on equity is 5.1%, and it has net margins of 5.8%.
Key information
15.6%
Earnings growth rate
3.4%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | 49.9% |
| Return on equity | 5.1% |
| Net Margin | 5.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,500 | 87 | 295 | 14 |
| 31 Dec 23 | 1,452 | 26 | 288 | 14 |
| 30 Sep 23 | 1,046 | 330 | 194 | 8 |
| 30 Jun 23 | 922 | 283 | 165 | 6 |
| 31 Mar 23 | 1,816 | -7 | 304 | 10 |
| 31 Dec 22 | 1,596 | 114 | 242 | 7 |
| 30 Sep 22 | 731 | 359 | 107 | 5 |
| 30 Jun 22 | 607 | 304 | 91 | 3 |
| 31 Mar 22 | 471 | 226 | 76 | 3 |
| 31 Dec 21 | 376 | 168 | 67 | 2 |
| 30 Sep 21 | 364 | 59 | 66 | 0 |
| 30 Jun 21 | 370 | 68 | 67 | 1 |
| 31 Mar 21 | 362 | 62 | 66 | 0 |
| 31 Dec 20 | 359 | 60 | 64 | 1 |
Quality Earnings: MEDTR has a high level of non-cash earnings.
Growing Profit Margin: MEDTR became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MEDTR's earnings have grown by 15.6% per year over the past 5 years.
Accelerating Growth: MEDTR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MEDTR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.9%).
Return on Equity
High ROE: MEDTR's Return on Equity (5.1%) is considered low.